Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4068 results

Sort By:

Inhaled Nitric Oxide in Severe Obesity

Study ID: NCT06675435
Start Date: 2025-10
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Nitric oxide

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma

Study ID: NCT07002216
Start Date: 2025-08-01
End Date: 2030-08-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

Bentuximab Vidotin

Etoposide

Cyclophosphamide

Doxorubicin

Dacarbazine

Dexamethasone

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Effects of Virtual Reality-Assisted Dual Task Training on Muscle Oxygenation in Patients With COPD

Study ID: NCT07015216
Start Date: 2025-07-12
End Date: 2026-01-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

VR-Assisted Dual Task Training

Conventional Therapy Program

Sponsor

Istinye University

Source: clinicaltrials.gov

Share:
Add to list

Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Study ID: NCT06497465
Start Date: 2025-07-14
End Date: 2029-01-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

150

Intervention / Treatment

Dolutegravir 50mg Tab

Dolutegravir/Lamivudine 50 MG-300mg Oral Tablet [DOVATO]

Dolutegravir plus Tenofovir disoproxil fumarate (TDF)/ lamivudine (3TC)

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Online RPG Interactive Adventure Games Combined With an E-book Learning Obstetric Fetal Heart Rate Monitoring Technology

Study ID: NCT06966960
Start Date: 2025-09-01
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Online RPG adventure games and e-book learning.

E-book

Sponsor

China Medical University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of a Therapeutic Yoga Program on Fatigue and Related Variables in Patients With Chronic Fatigue Syndrome or Long Covid

Study ID: NCT06978582
Start Date: 2025-10-01
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

147

Intervention / Treatment

Therapeutic conscious movement

Conventional exercise

Sponsor

University of Seville

Source: clinicaltrials.gov

Share:
Add to list

EQUITA - A Feasibility Trial of a Faith-placed Intervention to Increase Screening Uptake in Black Adults

Study ID: NCT06981182
Start Date: 2025-09-01
End Date: 2027-02-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Faith-placed intervention to promote breast, cervical, bowel, and AAA screening uptake in Black communities.

Sponsor

University of Sunderland

Source: clinicaltrials.gov

Share:
Add to list

A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults With Congenital Adrenal Hyperplasia

Study ID: NCT05663320
Start Date: 2025-06-26
End Date: 2025-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

virtual educational based transition intervention self-paced

Sponsor

National Institutes of Health Clinical Center (CC)

Source: clinicaltrials.gov

Share:
Add to list

AI-Driven Early Warning System for Perioperative Risks in Acute Hemorrhagic Stroke

Study ID: NCT06998082
Start Date: 2025-07-06
End Date: 2028-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1533

Intervention / Treatment
Sponsor

Beijing Tia N-hospital

Source: clinicaltrials.gov

Share:
Add to list

Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3

Study ID: NCT04637282
Start Date: 2026-03-01
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

39

Intervention / Treatment

PLX-200

Placebo

Sponsor

Polaryx Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list